Cite

HARVARD Citation

    Laino, A. et al. (2020). Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition. Journal for immunotherapy of cancer. 8 (1), p. . [Online]. 
  
Back to record